The test works by looking for cell-free nucleosomes in the blood. The study included 229 patients diagnosed with cancer and ...
The facility, which is set to open amid Biogen’s 50th anniversary, will integrate research and development, technical ...
Peter Ax, Founder & CEO of UpScriptHealth, discusses the impact of tariffs on the pharmaceutical industry, and how digital ...
The FDA has approved Novartis’ Fabhalta (iptacopan) as the first and only treatment for C3 glomerulopathy (C3G). Previously, patients with C3G were forced to rely on supportive care and broad ...
Halia won the award for its work with HT-6184, an inflammasome inhibitor that targets inflammation associated with obesity, metabolic dysfunction, and other related diseases.
Kimberley Chiang, vice president of biopharma commercial solutions at CoverMyMeds, discusses how the industry leverages data and technology to identify and address affordability issues before they ...
The investment, which is a 25% increase from previous years, will support three new advanced manufacturing facilities, ...
The Cigna Group Completes Sale of Medicare Businesses to HCSC. The Cigna Group. March 19, 2025.
DR-0201, a CD20-directed bispecific antibody, has demonstrated robust B-cell depletion in early clinical studies, showing ...
The Association of the British Pharmaceutical Industry (ABPI) reinstated Novo Nordisk’s membership in the group. 1 The ...
EVERSANA’s chief digital officer discusses recent developments in the pharma industry that are impacting its relationship ...
The deals are expected to shorten manufacturing timelines for cell therapies and reduce administration times for oncology ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results